Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using theemail support widget if the problem persists.
The following section summarizes insights on Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.'s Return on Common Equity:
We've identified the following companies as similar to Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
| Name | Ticker | Return on Common Equity |
|---|---|---|
| Cessatech AS | NGM:CESSA | -354.6% |
| Teva Pharmaceutical Industries Limited | DB:TEV | -25.5% |
| Viatris Inc | WBAG:VTRS | -3.2% |
| Aspen Pharmacare Holdings Limited | DB:LDZA | 5.2% |
| Nutex Befektetesi Nyrt | BUSE:NUTEX | 8.4% |
| Adcock Ingram Holdings Limited | JSE:AIP | 13.8% |
| Healthcare | SECTOR:HLTH.HU | 14.1% |
| Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. | OTCPK:RGED.F | 19.7% |
| Bausch Health Companies Inc | DB:BVF | NM |
| Hikma Pharmaceuticals PLC | DB:H5P | 15.9% |
| Cipla Limited | BDL:CIPLA | 18.8% |
| Endo Inc. | OTCPK:NDOI | 871.9% |
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Return on Common Equity in the popular category include:
A ratio used to measure the return that a firm generates on the book value of common equity.
Return on Common Equity is defined as:
Return on Common Equity = Net Income To Common / Average Total Common Equity
Return on Common Equity for Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt is calculated as follows:
Net Income [ 602.3 M ]
(/) Average Equity over Period [ 3.061 B ]
(=) Return on Common Equity [ 19.7% ]
The tables below summarizes the trend in Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt’s return on common equity over the last five years:
| Fiscal Year | Net Income | Average Common Equity | Return on Common Equity |
|---|---|---|---|
| 2020-12-31 | 352.7 M | 2.569 B | 13.7% |
| 2021-12-31 | 430 M | 2.651 B | 16.2% |
| 2022-12-31 | 453.2 M | 2.651 B | 17.1% |
| 2023-12-31 | 457.9 M | 3.163 B | 14.5% |
| 2024-12-31 | 602.3 M | 3.061 B | 19.7% |
Return on equity represents the percentage return a company generates on the money shareholders have invested.
The Net Income used in the numerator is often adjusted for one-time and non-recurring items to present a clearer view of future earnings. Since income is earned over the course of a year, we average book value of Common Equity at the start and end of the year for the denominator.
In general, a higher return on equity suggests management is utilizing the capital invested by shareholders efficiently.
The chart above depicts the distribution of Return on Common Equity for companies operating in the Healthcare Sector in the Developing economic region. Over 1,160 companies were considered in this analysis, and 1,122 had meaningful values. The average Return on Common Equity of companies in the Sector is 3.1% with a standard deviation of 18.4%. Please note that Sector and Industry values may differ from other sources, as no adjustments have been made.
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.'s Return on Common Equity of 19.7% ranks in the 90.3% percentile for the Sector. The following table provides additional summary stats:
| Economic Risk Region | Developing |
| Total Constituents | 1,168 |
| Included Constituents | 1,122 |
| Min | -131.2% |
| Max | 39.1% |
| Median | 5.9% |
| Mean | 3.1% |
| Standard Deviation | 18.4% |
You can find companies with similar Return on Common Equity using this stock screener.
The video below provides an overview of the key benefits to help you get the most out of InvestingPro.